Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Group 172477
version: 4; Last updated: 2023-12-04 16:22:16+0000
Profile: OutcomeDefinition
Artifact related artifact: No display for RelatedArtifact (type: cite-as; citation: OutcomeDefinition: HbA1c at 24 months [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 172477. Revised 2023-11-23. Available at: https://fevir.net/resources/Group/172477. Computable resource at: https://fevir.net/resources/Group/172477.)
Artifact Title: OutcomeDefinition: HbA1c at 24 months
Artifact URL: https://fevir.net/resources/Group/172477
Artifact Publisher: Computable Publishing LLC
Artifact Copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
Artifact use context: Evidence Communication = OutcomeDefinition
Artifact Contact: support@computablepublishing.com
Artifact Author: Brian S. Alper:
Artifact Status: active
identifier: FEvIR Object Identifier/172477
name: OutcomeDefinition_HbA1c_at_24_months
description:
HbA1c at 24 months
type: Animal
membership: Definitional
characteristic
org/fhir/uv/ebm/StructureDefinition/characteristic-description:
HbA1c at 24 months
CharacteristicTiming
- contextCode: Enrollment in clinical trial
- offset: No display for Duration (value: 24; unit: months; system: http://unitsofmeasure.org; code: mo)
- text: at 24 months
code: Observation
value: Hemoglobin A1c/Hemoglobin.total in Blood
exclude: false